Literature DB >> 17405948

Liposomal amphotericin B interferes with the phosphorus assay on the Synchron LX 20 analyzer.

Helen L Bailey, Emily M Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17405948     DOI： 10.1373/clinchem.2006.078840

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  3 in total

1.  Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.

Authors:  Chad A Knoderer; Holly M Knoderer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B.

Authors:  Nicole M Bohm; Katherine C Hoover; Amy E Wahlquist; Yusheng Zhu; Juan Carlos Q Velez
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

3.  Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

Authors:  Jason W Lane; Nadja N Rehak; Glen L Hortin; Theoklis Zaoutis; Philip R Krause; Thomas J Walsh
Journal:  Clin Chim Acta       Date:  2007-08-30       Impact factor: 3.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.